Today: 7 February 2026
Subscribe

Meta stock slides after FTC revives Instagram-WhatsApp antitrust fight, with earnings next week

Meta stock slides after FTC revives Instagram-WhatsApp antitrust fight, with earnings next week

Meta Platforms shares fell 2.5% to $604.12 in after-hours trading Tuesday after the U.S. FTC said it will appeal a court ruling dismissing its antitrust case over Meta’s Instagram and WhatsApp acquisitions. The move comes days before Meta’s earnings and as UK regulators criticized Meta for allowing illegal gambling ads. Alphabet, Snap, and Pinterest also posted losses.
20 January 2026
·
Broadcom stock slides 5% after-hours as Trump tariff threat sparks risk-off tech selloff

Broadcom stock slides 5% after-hours as Trump tariff threat sparks risk-off tech selloff

Broadcom shares fell 5.4% to $332.60 in after-hours trading, following a sharp selloff in tech stocks after President Trump threatened new tariffs on European goods. The Dow lost 1.75%, S&P 500 dropped 1.97%, and Nasdaq fell 2.19%. The dollar slid, while gold and silver hit new highs. Trump’s tariffs on imports from eight European countries take effect Feb. 1, rising to 25% in June if no deal is reached.
20 January 2026
·
Microsoft stock dips after-hours as Bristol Myers AI lung-cancer deal lands and tariff jitters shake tech

Microsoft stock dips after-hours as Bristol Myers AI lung-cancer deal lands and tariff jitters shake tech

Microsoft shares fell 1.1% to $454.52 in after-hours trading Tuesday, tracking a broad tech selloff as tariff concerns rattled markets. Bristol Myers Squibb announced a partnership to use Microsoft’s AI radiology tools for early lung cancer detection. Investors are awaiting Microsoft’s fiscal Q2 earnings on Jan. 28 for updates on cloud and AI growth. The S&P 500 closed down 2.04%, Nasdaq off 2.38%.
20 January 2026
···
Amazon stock slides after Jassy warns tariffs are creeping into prices

Amazon stock slides after Jassy warns tariffs are creeping into prices

Amazon shares fell 3.4% to $231 in after-hours trading Tuesday after CEO Andy Jassy warned tariffs are starting to lift prices and dampen demand. U.S. tariff threats from President Trump rattled markets, sending the S&P 500 ETF down 2.1%. Investors are watching Amazon’s Feb. 5 earnings for signs of further impact. Walmart and Target also declined.
20 January 2026
·····
Tesla stock drops 4% as tech selloff bites; Musk chip push and Canada tariffs in focus

Tesla stock drops 4% as tech selloff bites; Musk chip push and Canada tariffs in focus

Tesla shares fell 4.2% Tuesday to $419.25, then slipped to $418.86 after hours amid a broader tech selloff. CEO Elon Musk highlighted progress on Tesla’s AI chip and Dojo3 project. The drop followed tariff threats from President Trump and ahead of Tesla’s Jan. 28 earnings report. Canada will allow limited imports of Chinese-made vehicles, but most Tesla models exceed the price cap.
20 January 2026
···
Nvidia stock price drops 4% as Trump tariff threats hit tech; China H200 decision stalls

Nvidia stock price drops 4% as Trump tariff threats hit tech; China H200 decision stalls

Nvidia shares fell 4.3% to $178.20 Tuesday after President Trump raised tariff threats and reports surfaced of export hurdles for its H200 AI chip to China. The S&P 500 dropped 2.04% and the Nasdaq slid 2.38%. Taiwan’s Inventec said the H200 chip remains blocked by Chinese customs despite recent U.S. approval. Nvidia also invested in AI startup Humans&, which raised $480 million at a $4.48 billion valuation.
20 January 2026
··
Gilead stock steadies in Wall Street selloff as Bernstein sticks with $135 target and Florida HIV funding shifts loom

Gilead stock steadies in Wall Street selloff as Bernstein sticks with $135 target and Florida HIV funding shifts loom

Gilead Sciences shares slipped 0.2% to $124.68 Tuesday, outperforming a broader market drop. Bernstein reiterated its Outperform rating and $135 target, citing Yeztugo as a key 2026 driver. Florida announced steep cuts to its AIDS Drug Assistance Program, drawing criticism from advocates and raising concerns over HIV drug access.
20 January 2026
··
Texas Instruments stock slides as tariff headlines jolt tech — what to watch before TXN earnings

Texas Instruments stock slides as tariff headlines jolt tech — what to watch before TXN earnings

Texas Instruments shares fell about 1.6% to $188.42 Tuesday, tracking a broader market sell-off as the S&P 500 SPDR fund dropped 2%. The iShares Semiconductor ETF also lost 1.6%. Investors are watching ahead of Texas Instruments’ fourth-quarter earnings, set for release after markets close Jan. 27. Tariff threats from President Trump contributed to market volatility.
20 January 2026
······
GE Aerospace stock slides 3% as traders brace for earnings and a new CFM maintenance pact

GE Aerospace stock slides 3% as traders brace for earnings and a new CFM maintenance pact

GE Aerospace shares fell 3.3% to $314.39 Tuesday, dropping $10.73 from the previous close ahead of its Jan. 22 earnings report. IATA and CFM International, a GE-Safran joint venture, extended their engine maintenance competition agreement through February 2033. Investors are watching for updates on supply bottlenecks and service demand.
20 January 2026
···
Lockheed Martin stock price dips as Davos criticism and Greenland tariff threats rattle defense names

Lockheed Martin stock price dips as Davos criticism and Greenland tariff threats rattle defense names

Lockheed Martin shares fell 1.1% to $576.12 Tuesday amid new trade tensions after President Trump’s Greenland move triggered tariff threats against Europe. RTX, Northrop Grumman, and General Dynamics also declined. EU leaders plan an emergency summit Thursday to discuss retaliatory tariffs on $108 billion of U.S. goods. Lockheed will report earnings Jan. 29.
20 January 2026
·····
Home Depot stock price slips as tariff fears hit retailers, even after TD Cowen raises target

Home Depot stock price slips as tariff fears hit retailers, even after TD Cowen raises target

Home Depot shares fell 1.4% to $374.87 Tuesday after President Trump announced new tariffs on European imports, sparking a broader selloff in consumer stocks. Lowe’s dropped 3.4%, and the SPDR S&P Homebuilders ETF lost 2.2%. Home Depot’s price target was raised to $450 by TD Cowen, but concerns remain over pricing power and flat housing activity.
20 January 2026
··
Coca-Cola stock price rises as tariff fears rattle markets — what KO investors watch next

Coca-Cola stock price rises as tariff fears rattle markets — what KO investors watch next

Coca-Cola shares rose 1.3% to $71.37 Tuesday afternoon, bucking a broader market selloff triggered by new U.S. tariff threats against Europe. CEO James Quincey said the company is “relatively immune to tariffs” ahead of its Feb. 10 earnings report. The S&P 500 and Nasdaq fell to one-month lows. EU leaders plan an emergency summit Thursday to discuss possible retaliatory tariffs.
20 January 2026
·
1 … 295 296 297 298 299 … 1,631

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop